Overview
McDermott Will & Emery, a leading global law firm today announced that David Revcolevschi has joined the Firm’s Paris office as a partner. David’s arrival strengthens an already robust corporate team in France, with a focus on capital markets and securities law.
“David’s reputation in capital markets brings our clients a new depth of experience on our corporate M&A team, complementing our industry-leading private equity and industrial M&A practices. His sector-based approach, particularly in health and technology, also aligns with our development strategy,” said Grégoire Andrieux, Managing Partner of the Paris office.
“We are growing, both in Paris and around the world. We want to do this in a coherent client-focused fashion, by attracting lawyers with complementary skills that can contribute to, and feed into our existing activities, while adding value to for our clients. David’s arrival fits in perfectly with this strategy,” added Grégoire.
David mainly advises on capital market and M&A transactions in France and abroad and more generally on all aspects of the life and governance of listed companies. He has extensive experience in cross border transactions, in particular in the field of securities offerings, as counsel to issuers, banks and shareholders.
In particular, he has advised on more than 30 IPO projects and on numerous other equity or equity-linked securities offering transactions carried out by companies operating in various sectors, in particular, the life sciences (biotech, medical devices) and technology (software, semiconductors, equipments, IT services, telecom) sectors, as well as in the air transport, aeronautic, real estate, leisure, chemical, infrastructure, and financial institutions sectors. He also acts in enforcement actions involving issuers or their managers and employees before the French Financial Markets Authority (AMF).
“McDermott is widely respected for its focus on providing outstanding counsel to its clients and for its inclusive, collaborative and truly international culture. I am delighted to be joining one of the most recognized and respected legal teams in the healthcare, life sciences and healthtech sectors,” said David.
David was a Fulbright Scholar at Harvard Law School and holds a Master’s degree in Business Law, a Master’s degree in Public Law, and a Master’s degree in the History of International Relations from the University of Paris I – Panthéon-Sorbonne.
Prior to joining McDermott, David practiced at Paul Hastings, Freshfields Bruckhaus Deringer and Skadden Arps.
David is recognized as one of the market leaders in capital markets by Legal 500 Paris, Chambers, IFLR 1000, and by his peers in the Best Lawyers Guide.
McDermott Will & Emery’s Paris office now has 24 partners, including 16 partners in the Corporate Department, for a total of 80 lawyers.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 20 locations on three continents, our team works seamlessly across practices, industries and geographies to deliver highly effective—and often unexpected—solutions that propel success. More than 1,100 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
